COMMUNIQUÉS West-GlobeNewswire

Silo Pharma Updates Strategic Agreement with Fireblocks to Secure Crypto Treasury Management
29/09/2025
Fireblocks is a globally recognized leader in the digital assets space, facilitating the secure transfer of more than $10 trillion to date SARASOTA, FL, Sept. 29, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO [...]
Lighthouse Autism Center Announces Expansion in North Carolina with High Point Location
29/09/2025
ABA Provider Expands in North Carolina to Meet Growing Need for Autism Services MISHAWAKA, Ind., Sept. 29, 2025 (GLOBE NEWSWIRE) -- Lighthouse Autism Center, a premier provider of center-based Applied Behavior Analysis [...]
Compass Health CEO honored with Lifetime Achievement Award from Vistage, the world’s largest CEO coaching and advisory organization
29/09/2025
The Lifetime Achievement Award recognizes a veteran member of 10+ years with a track record of bold decisions benefitting the company, community and beyond EVERETT, Wash., Sept. 29, 2025 (GLOBE NEWSWIRE) -- Compass [...]
Glo & Spa-rkle Aesthetics and Medical Spa Launches Revolutionary Near-Painless and Precise PRP and PRF Hair Restoration Intradermal Injector Treatment
29/09/2025
Introducing Mesogun Intradermal Injection Technology for a Painless and Precise Hair Restoration Experience Lubbock, TX, Sept. 29, 2025 (GLOBE NEWSWIRE) -- Glo & Spa-rkle Aesthetics and Medical Spa, a leading name [...]
Persephone Biosciences Co-Sponsors Event With Clean Label Project At Annual American Academy Of Pediatrics Conference
29/09/2025
Persephone’s Daily Synergistic Synbiotic Is The First Synbiotic To Receive Clean Label Project First 1,000 Days Promise Certification DENVER, Sept. 29, 2025 (GLOBE NEWSWIRE) -- Persephone Biosciences , a pioneering [...]
Arcutis Biotherapeutics to Host Virtual Investor Day and Report Third Quarter 2025 Financial Results on October 28, 2025
29/09/2025
WESTLAKE VILLAGE, Calif., Sept. 29, 2025 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on immuno-dermatology, today announced that it will report [...]
Consortium consisting of Nordic Capital and Permira extends offer period until 14 October 2025 and provides update on regulatory approvals in respect of the takeover offer to the shareholders of Bavarian Nordic
29/09/2025
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR TO ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION COPENHAGEN, Denmark, [...]
Spectral Medical Inc. Files Base Shelf Prospectus and Revised AIF
29/09/2025
TORONTO, Sept. 29, 2025 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“ Spectral” or the “Company” ) (TSX: EDT) , a late-stage theranostic company advancing therapeutic options for sepsis and septic shock, announced that [...]
Tria Federal Unveils Tria Forge, a Serverless AI Platform That Empowers Organizations to Build Secure, Codeless AI Tools
29/09/2025
ARLINGTON, Va., Sept. 29, 2025 (GLOBE NEWSWIRE) -- Tria Federal today announced the launch of Tria Forge , a secure, serverless generative AI platform that empowers customers to build and deploy AI tools tailored to [...]
Fagron increases share capital through exercise subscription rights
29/09/2025
Regulated information Nazareth (Belgium)/Rotterdam (The Netherlands), 29 September 2025 – 7PM CET Fagron increases share capital through exercise subscription rights Fagron announces that as a result of the exercise of [...]
MindRank Announces Positive 12-week Once-Daily (QD) Results for AI-Designed Oral GLP-1 Agonist MDR-001 in Adults with Obesity
29/09/2025
HANGZHOU, China and LONDON, Sept. 29, 2025 (GLOBE NEWSWIRE) -- MindRank AI Ltd., a clinical-stage artificial intelligence (AI)-empowered drug discovery company, today announced the positive topline results of its oral [...]
Reflect Scientific Secures Over $1 Million in Follow-On Orders for B-90 Blast Freezer
29/09/2025
OREM, Utah, Sept. 29, 2025 (GLOBE NEWSWIRE) -- Reflect Scientific, Inc. (Symbol: RSCF), a provider of advanced cryogenic cooling solutions, today announced it has received follow-on orders totaling more than $1 million [...]
Provectus Biopharmaceuticals Initiates Preclinical Study of Oral PV-10 in Bladder Cancer
29/09/2025
KNOXVILLE, Tenn., Sept. 29, 2025 (GLOBE NEWSWIRE) -- Provectus Biopharmaceuticals, Inc. (“Provectus” or the “Company”) (OTCQB: PVCT) today announced the start of a preclinical study of its lead investigational drug PV- [...]
Apyx Medical to Host Virtual Key Opinion Leader Event to Discuss the Commercial Launch of The AYON Body Contouring System™ on October 14, 2025
29/09/2025
CLEARWATER, Fla., Sept. 29, 2025 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) (“Apyx Medical;” the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and [...]
Calidi Biotherapeutics to Present at the second annual Oncology Venture, Innovation, and Partnering Summit in Boston
29/09/2025
SAN DIEGO, Sept. 29, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (NYSE American: CLDI) (“Calidi” or the “Company”), a clinical-stage biotechnology company pioneering the development of targeted therapies with [...]
Humacyte Announces Expansion of Intellectual Property for Pipeline Products with Granting of New U.S. Patent for Bioengineered Esophagus
29/09/2025
– Patent covers esophagus produced using Humacyte’s proprietary bioengineered regenerative tissue platform, designed for implant in patients with damaged esophagus – – Patent provides coverage into 2041 for the [...]
electroCore Announces Reimbursement Approval for gammaCore™ by RIZIV/INAMI in Belgium
29/09/2025
ROCKAWAY, N.J., Sept. 29, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that gammaCore™ Sapphire (nVNS) has been included in a [...]
MBX Biosciences to Participate in the Stifel 2025 Virtual Cardiometabolic Forum
29/09/2025
CARMEL, Ind., Sept. 29, 2025 (GLOBE NEWSWIRE) -- MBX Biosciences, Inc. (Nasdaq: MBX), a clinical-stage biopharmaceutical company focused on the discovery and development of novel precision peptide therapies for the [...]
INmune Bio Announces Submission of Phase 2 MINDFuL Trial Results in Alzheimer’s Disease to npj Dementia, a Nature Portfolio Journal
29/09/2025
Boca Raton, FL, Sept. 29, 2025 (GLOBE NEWSWIRE) -- INmune Bio, Inc. (NASDAQ: INMB), a clinical-stage inflammation and immunology company, today announces the submission of a manuscript detailing the results of its Phase [...]

Pages